BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 32352211)

  • 1. HIP/PAP protects against bleomycin-induced lung injury and inflammation and subsequent fibrosis in mice.
    Zheng X; Li Q; Tian H; Li H; Lv Y; Wang Y; He L; Huo Y; Hao Z
    J Cell Mol Med; 2020 Jun; 24(12):6804-6821. PubMed ID: 32352211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein (HIP/PAP) confers protection against hepatic fibrosis through downregulation of transforming growth factor β receptor II.
    Li Q; Li H; Lv Y; Zhang Q; Zhang X; Li S; Zheng X; Wang Y; Hao Z
    Lab Invest; 2020 Mar; 100(3):466-482. PubMed ID: 31641222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
    Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF
    Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition.
    Gao L; Jiang D; Geng J; Dong R; Dai H
    Exp Physiol; 2019 Dec; 104(12):1942-1951. PubMed ID: 31535412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dasatinib Suppresses TGFβ-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis.
    Kanemaru R; Takahashi F; Kato M; Mitsuishi Y; Tajima K; Ihara H; Hidayat M; Wirawan A; Koinuma Y; Hayakawa D; Yagishita S; Ko R; Sato T; Harada N; Kodama Y; Nurwidya F; Sasaki S; Niwa SI; Takahashi K
    Lung; 2018 Oct; 196(5):531-541. PubMed ID: 29926178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective role of gambogic acid in experimental pulmonary fibrosis in vitro and in vivo.
    Qu Y; Zhang G; Ji Y; Zhua H; Lv C; Jiang W
    Phytomedicine; 2016 Apr; 23(4):350-8. PubMed ID: 27002405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ponatinib ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway.
    Qu Y; Zhang L; Kang Z; Jiang W; Lv C
    Pulm Pharmacol Ther; 2015 Oct; 34():1-7. PubMed ID: 26254990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YY1 mediates TGF-β1-induced EMT and pro-fibrogenesis in alveolar epithelial cells.
    Zhang C; Zhu X; Hua Y; Zhao Q; Wang K; Zhen L; Wang G; Lü J; Luo A; Cho WC; Lin X; Yu Z
    Respir Res; 2019 Nov; 20(1):249. PubMed ID: 31703732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
    Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
    Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein suppresses dextran sulfate sodium-induced acute ulcerative colitis in rats.
    Lv Y; Yang X; Huo Y; Tian H; Li S; Yin Y; Hao Z
    Inflamm Bowel Dis; 2012 Oct; 18(10):1950-60. PubMed ID: 22419609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation.
    Guan R; Wang X; Zhao X; Song N; Zhu J; Wang J; Wang J; Xia C; Chen Y; Zhu D; Shen L
    Sci Rep; 2016 Oct; 6():35696. PubMed ID: 27774992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo.
    Ota C; Yamada M; Fujino N; Motohashi H; Tando Y; Takei Y; Suzuki T; Takahashi T; Kamata S; Makiguchi T; Yamaya M; Kubo H
    Exp Lung Res; 2015; 41(8):422-34. PubMed ID: 26151196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
    Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
    J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Wnt/β-catenin signaling suppresses bleomycin-induced pulmonary fibrosis by attenuating the expression of TGF-β1 and FGF-2.
    Chen X; Shi C; Meng X; Zhang K; Li X; Wang C; Xiang Z; Hu K; Han X
    Exp Mol Pathol; 2016 Aug; 101(1):22-30. PubMed ID: 27112840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive effects of Ecliptae Herba extract and its component, ecliptasaponin A, on bleomycin-induced pulmonary fibrosis in mice.
    You XY; Xue Q; Fang Y; Liu Q; Zhang CF; Zhao C; Zhang M; Xu XH
    J Ethnopharmacol; 2015 Dec; 175():172-80. PubMed ID: 26385580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of PIM1 kinase attenuates bleomycin-induced pulmonary fibrosis in mice by modulating the ZEB1/E-cadherin pathway in alveolar epithelial cells.
    Zhang X; Zou Y; Liu Y; Cao Y; Zhu J; Zhang J; Chen X; Zhang R; Li J
    Mol Immunol; 2020 Sep; 125():15-22. PubMed ID: 32619930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective Effect of Atazanavir Sulphate Against Pulmonary Fibrosis In Vivo and In Vitro.
    Song S; Ji Y; Zhang G; Zhang X; Li B; Li D; Jiang W
    Basic Clin Pharmacol Toxicol; 2018 Feb; 122(2):199-207. PubMed ID: 28816009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exogenous angiotensin (1-7) directly inhibits epithelial-mesenchymal transformation induced by transforming growth factor-β1 in alveolar epithelial cells.
    Shao M; Wen ZB; Yang HH; Zhang CY; Xiong JB; Guan XX; Zhong WJ; Jiang HL; Sun CC; Luo XQ; He XF; Zhou Y; Guan CX
    Biomed Pharmacother; 2019 Sep; 117():109193. PubMed ID: 31387171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective roles of pulmonary rehabilitation mixture in experimental pulmonary fibrosis in vitro and in vivo.
    Zhang L; Ji YX; Jiang WL; Lv CJ
    Braz J Med Biol Res; 2015 Jun; 48(6):545-52. PubMed ID: 25992646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol ameliorates lipopolysaccharide-induced epithelial mesenchymal transition and pulmonary fibrosis through suppression of oxidative stress and transforming growth factor-β1 signaling.
    Zhang YQ; Liu YJ; Mao YF; Dong WW; Zhu XY; Jiang L
    Clin Nutr; 2015 Aug; 34(4):752-60. PubMed ID: 25234611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.